# FDA Inspection 1015621 - CSL Plasma Inc. - May 26, 2017

Source: https://www.globalkeysolutions.net/records/fda_inspections/csl-plasma-inc/e37da5fb-71d8-4513-a1d8-6700d3b99306
Source feed: FDA_Inspections

> FDA Inspection 1015621 for CSL Plasma Inc. on May 26, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1015621
- Company Name: CSL Plasma Inc.
- Inspection Date: 2017-05-26
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1083431 - 2019-03-06](https://www.globalkeysolutions.net/records/fda_inspections/csl-plasma-inc/da17bbb7-c1c6-4d1c-b58e-a79388a8618d)
- [FDA Inspection 887174 - 2014-06-18](https://www.globalkeysolutions.net/records/fda_inspections/csl-plasma-inc/b091811a-4a81-42fa-ab74-20b444560f44)

Company: https://www.globalkeysolutions.net/companies/csl-plasma-inc/a4bffc33-58c5-450b-ba0d-23de935f664d

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d